Audio Insights

William Morice, II, M.D., Ph.D., sat down with Marie Brown to recap her time spent at Mayo Clinic and wish her well in her retirement.

Linnea Baudhuin, Ph.D., Co-Director of the Personalized Genomics Laboratory at Mayo Clinic, provides an overview of the new familial hereditary hemorrhagic telangiectasia gene panel available through Mayo Medical Laboratories. She discusses which types of patients should be tested, how this approach improves upon previous methods, and what clinical action can be taken from the results of this test.

Linnea Baudhuin, Ph.D., Co-Director of the Personalized Genomics Laboratory at Mayo Clinic, provides an overview of the new familial hereditary hemorrhagic telangiectasia gene panel available through Mayo Medical Laboratories. She discusses which types of patients should be tested, how this approach improves upon previous methods, and what clinical action can be taken from the results of this test.

Linnea Baudhuin, Ph.D., Co-Director of the Personalized Genomics Laboratory at Mayo Clinic, provides an overview of the new familial hereditary hemorrhagic telangiectasia gene panel available through Mayo Medical Laboratories. She discusses which types of patients should be tested, how this approach improves upon previous methods, and what clinical action can be taken from the results of this test.

Linnea Baudhuin, Ph.D., Co-Director of the Personalized Genomics Laboratory at Mayo Clinic, provides an overview of the new familial hereditary hemorrhagic telangiectasia gene panel available through Mayo Medical Laboratories. She discusses which types of patients should be tested, how this approach improves upon previous methods, and what clinical action can be taken from the results of this test.

Jane Hermansen is the manager for the Mayo Medical Laboratories Outreach and Network Development Program and the chair for the Leveraging the Laboratory Conference taking place on September 18-19, 2018 in Rochester, Minnesota.

Andrew McKeon, M.D., M.B., B.Ch. and Eati Basal, Ph.D. discuss their presentation during the MS and CNS Inflammatory Disease: Basic session at AAN 2018.

Shirley Roque is an Outreach Program Coordinator for Mayo Medical Laboratories and is on the planning committee for the Leveraging the Laboratory Conference that is taking place on September 18-19, 2018 in Rochester, Minnesota.

A. Sebastian Lopez Chiriboga, M.D. discusses his presentation during the Neuromyelitis Optica Spectrum Disorder and other Autoimmune Disorders session during AAN 2018.

Christopher Klein, a Neurologist at Mayo Clinic, provides an overview of neuromuscular testing through Mayo Medical Laboratories. He discusses which types of patients should be tested, the benefits of our approach, how this approach improves upon previous methods, and the role that functional assays play in diagnosis.